Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. | SVP, Chief Accounting Officer | Common Stock | 220K | $269K | $1.22 | May 12, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKBA | Akebia Therapeutics, Inc. | May 12, 2022 | 1 | $0 | 4 | May 16, 2022 | SVP, Chief Accounting Officer |
AKBA | Akebia Therapeutics, Inc. | Feb 28, 2022 | 3 | -$8.5K | 4 | Mar 2, 2022 | SVP, Chief Accounting Officer |
AKBA | Akebia Therapeutics, Inc. | Jan 3, 2022 | 1 | -$13.3K | 4 | Jan 5, 2022 | SVP, Chief Accounting Officer |